CAMK4

Azuah L Gonzalez1, Cristina M Youwakim2,3, Brenda F Leake2,3

  • 1Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN. (A.L.G., M.M.D., A.B.C., K.C.V., A.C.D.).

概括

向/卡尔莫杜林依赖蛋白激酶IV (CaMK4) 可能会减少动脉样硬化的进展. 在小鼠中,CaMK4的丧失导致了较小,更稳定的病变和亲修复性髓状细胞表型,这表明了新的治疗标.